Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/92019/1/21673_ftp.pd
Purpose of review Precision medicine is an evolving field stemming from Oncology research, with an ...
Systemic sclerosis (SSc) is a complex rare autoimmune disease with heterogeneous clinical manifestat...
Systemic sclerosis (SSc) is a rare disease that preferentially affects females, with a reported fema...
by Mendoza et al about clinical trial design in systemic sclerosis (SSc; scleroderma) suggests that ...
The purpose of this manuscript is to discuss relevant aspects of clinical trials for Systemic Sclero...
Objective. SSc is clinically and aetiopathogenically heterogeneous. Consensus standards for more uni...
Scleroderma is clinically heterogeneous and a variety of plausible mechanisms of disease have been h...
Systemic sclerosis–associated interstitial lung disease remains a leading cause of mortality. Despit...
OBJECTIVE: To estimate the extent of and the reasons for ineligibility in randomized controlled tria...
The pathogenesis of systemic sclerosis (SSc) is complex, and the final story is yet to be elucidated...
Introduction: Systemic sclerosis (SSc) is a chronic, autoimmune connective tissue disease associated...
While significant progress has been made in treating systemic sclerosis, many patients still have an...
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/155996/1/art41246_am.pdfhttps://deepbl...
Introduction Systemic sclerosis (SSc) is a chronic, autoimmune connective tissue disease associated ...
OBJECTIVE: There is a lack of agreement regarding treatment for many aspects of systemic sclerosis (...
Purpose of review Precision medicine is an evolving field stemming from Oncology research, with an ...
Systemic sclerosis (SSc) is a complex rare autoimmune disease with heterogeneous clinical manifestat...
Systemic sclerosis (SSc) is a rare disease that preferentially affects females, with a reported fema...
by Mendoza et al about clinical trial design in systemic sclerosis (SSc; scleroderma) suggests that ...
The purpose of this manuscript is to discuss relevant aspects of clinical trials for Systemic Sclero...
Objective. SSc is clinically and aetiopathogenically heterogeneous. Consensus standards for more uni...
Scleroderma is clinically heterogeneous and a variety of plausible mechanisms of disease have been h...
Systemic sclerosis–associated interstitial lung disease remains a leading cause of mortality. Despit...
OBJECTIVE: To estimate the extent of and the reasons for ineligibility in randomized controlled tria...
The pathogenesis of systemic sclerosis (SSc) is complex, and the final story is yet to be elucidated...
Introduction: Systemic sclerosis (SSc) is a chronic, autoimmune connective tissue disease associated...
While significant progress has been made in treating systemic sclerosis, many patients still have an...
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/155996/1/art41246_am.pdfhttps://deepbl...
Introduction Systemic sclerosis (SSc) is a chronic, autoimmune connective tissue disease associated ...
OBJECTIVE: There is a lack of agreement regarding treatment for many aspects of systemic sclerosis (...
Purpose of review Precision medicine is an evolving field stemming from Oncology research, with an ...
Systemic sclerosis (SSc) is a complex rare autoimmune disease with heterogeneous clinical manifestat...
Systemic sclerosis (SSc) is a rare disease that preferentially affects females, with a reported fema...
DOI
Add to ORKG